🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Yong Zhu

Obstetrics and Gynecology Hospital of Fudan University

ORCID: 0000-0002-7468-8798
MedicineBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile
0Author DataRank

Indexed papers

1in pilot corpus
datarank_citation_only_1hop_v6· scope data_onlyMethodology
Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 1 indexed paper attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

Papers

Driven by 4 papers. Top paper: “Liver epigenomic signature associated with chronic oxidative stress in a mouse model of glutathione deficiency”.

Liver epigenomic signature associated with chronic oxidative stress in a mouse model of glutathione deficiency

Chemico-Biological Interactions(2024)10.1016/j.cbi.2024.111093
N/A
0.241DataRank · unranked
4 citations

Xiaoqing Yu, Yong Zhu, Ying Chen, Seong Hwi Hong

Persistence with once-weekly glucagon-like peptide 1 receptor agonist therapy decreases the risk of major adverse cardiovascular events: A retrospective analysis of patients with type 2 diabetes mellitus and atherosclerotic cardiovascular disease

Diabetes Research and Clinical Practice(2025)10.1016/j.diabres.2025.112162
N/A
0.241DataRank · unranked
4 citations

Yong Zhu, Noelle N. Gronroos, Lin Xie, Andrew Sargent, Cory Gamble +2 more

Highlights of Antibody Engineering and Therapeutics 2019 in San Diego, USA: Bispecific Antibody Design and Clinical Applications

Antibody Therapeutics(2020)10.1093/abt/tbaa012
N/A
0DataRank · unranked
7 citations

Run Shen, Rui Hao, Shouye Wang, Mitchell Ho, Yong Zhu

The emergence of AntibodyPlus: the future trend of antibody-based therapeutics

Antibody Therapeutics(2022)10.1093/abt/tbac024
N/A
0DataRank · unranked
14 citations

Shawn Shouye Wang, Zhaohui Sunny Zhou, Mitchell Ho, Yong Zhu